Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐ CHOP

Bouska, A., Bi, C., Lone, W., Zhang, W., Kedwaii, A., Heavican, T., Lachel, C.M., Yu, J., Ferro, R., Eldorghamy, N., Greiner, T.C., Vose, J., Weisenburger, D.D., Gascoyne, R.D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L.M., Jaffe, E.S., Braziel, R.M., Siebert, R., Miles, R.R., Dave, S., Reddy, A., Delabie, J., Staudt, L.M., Song, J.Y., McKeithan, T.W., Fu, K., Green, M., Chan, W.C. & Iqbal, J. (2017) Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. Blood, 130, 1819–1831. Devan, J., Janikova, A. & Mraz, M. (2018) New concepts in follicular lymphoma biology: from BCL2 to epigenetic regulators and non-coding RNAs. Seminars in Oncology, 45, 291–302. Gunn, S.R., Bolla, A.R., Barron, L.L., Gorre, M.E., Mohammed, M.S., Bahler, D.W., Mellink, C.H., van Oers, M.H., Keating, M.J., Ferrajoli, A., Coombes, K.R., Abruzzo, L.V. & Robetorye, R.S. (2009) Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. Leukemia Research, 33, 1276–1281. Hadzidimitriou, A., Darzentas, N., Murray, F., Smilevska, T., Arvaniti, E., Tresoldi, C., Tsaftaris, A., Laoutaris, N., Anagnostopoulos, A., Davi, F., Ghia, P., Rosenquist, R., Stamatopoulos, K. & Belessi, C. (2009) Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood, 113, 403–411. Kolquist, K.A., Schultz, R.A., Slovak, M.L., McDaniel, L.D., Brown, T.C., Tubbs, R.R., Cook, J.R., Theil, K.S., Cawich, V., Valentin, C., Minier, S., Neill, N.J., Byerly, S., Morton, S.A., Sahoo, T., Ballif, B.C. & Shaffer, L.G. (2011) Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis. Molecular Cytogenetics, 4, 25. Mestichelli, F., Dalsass, A., Ferretti, S., Camaioni, E., Angelini, M., Mei, S., Pezzoni, V., Travaglini, F., Troiani, E., Angelini, S. & Galieni, P. (2018) Array CGH analysis reveals deletion of chromosome 22q11 in CLL with normal karyotype and no fish alterations. British Journal of Haematology, 183, 152–155. Minden, M.D., Ubelhart, R., Schneider, D., Wossning, T., Bach, M.P., Buchner, M., Hofmann, D., Surova, E., Follo, M., Kahler, F., Wardemann, H., Zirlik, K., Veelken, H. & Jumaa, H. (2012) Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature, 489, 309–312. Mraz, M., Dolezalova, D., Plevova, K., Stano Kozubik, K., Mayerova, V., Cerna, K., Musilova, K., Tichy, B., Pavlova, S., Borsky, M., Verner, J., Doubek, M., Brychtova, Y., Trbusek, M., Hampl, A., Mayer, J. & Pospisilova, S. (2012) MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood, 119, 2110–2113. Mraz, M., Stano Kozubik, K., Plevova, K., Musilova, K., Tichy, B., Borsky, M., Kuglik, P., Doubek, M., Brychtova, Y., Mayer, J. & Pospisilova, S. (2013) The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. Leukemia Research, 37, 802–808. Stamatopoulos, B., Smith, T., Crompot, E., Pieters, K., Clifford, R., Mraz, M., Robbe, P., Burns, A., Timbs, A., Bruce, D., Hillmen, P., Meuleman, N., Mineur, P., Firescu, R., Maerevoet, M., De Wilde, V., Efira, A., Philippe, J., Verhasselt, B., Offner, F., Sims, D., Heger, A., Dreau, H. & Schuh, A. (2018) The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: results of a multicenter study. Clinical Cancer Research, 24, 5048–5057.